Chu A, Wei W, Liu N, Zhang F, Zhang X, Li X
Front Med (Lausanne). 2024; 11:1450561.
PMID: 39380733
PMC: 11458470.
DOI: 10.3389/fmed.2024.1450561.
Marrone G, Urciuoli S, Di Lauro M, Cornali K, Montalto G, Masci C
Nutrients. 2024; 16(14).
PMID: 39064764
PMC: 11279474.
DOI: 10.3390/nu16142319.
Muthuraman A, Sayem A, Meenakshisundaram S, Ali N, Ahmad S, Alasmari A
Biomedicines. 2023; 11(10).
PMID: 37893028
PMC: 10603961.
DOI: 10.3390/biomedicines11102654.
Adam G, Adam A, Robu S, Harabor V, Harabor A, Nechita A
Pharmaceuticals (Basel). 2023; 16(7).
PMID: 37513901
PMC: 10385934.
DOI: 10.3390/ph16070988.
Ji B, Liu J, Ma Y, Yin Y, Xu H, Shen Q
Appl Biochem Biotechnol. 2023; 195(12):7379-7396.
PMID: 37000351
PMC: 10754751.
DOI: 10.1007/s12010-023-04333-z.
A worldwide bibliometric analysis of triptolide research from 1997 to 2021.
Ji B, Cai Z, Liu D, Ding Y, Zhang Y, Naranmandakh S
Am J Transl Res. 2022; 14(10):7290-7307.
PMID: 36398275
PMC: 9641448.
Research and application of herbal medicine in the treatment of chronic kidney disease since the 21st century: A visualized bibliometric analysis.
Xu Y, Chen J, Wang H, Lu Y
Front Pharmacol. 2022; 13:971113.
PMID: 36249821
PMC: 9561987.
DOI: 10.3389/fphar.2022.971113.
The Effect of Saffron (Crocus sativus L.) Supplementation on Renal Function: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
Karimi E, Shahdadian F, Hadi A, Tarrahi M, Tarrahi M
Int J Clin Pract. 2022; 2022:9622546.
PMID: 36105788
PMC: 9444416.
DOI: 10.1155/2022/9622546.
Traditional Chinese Medicine in the Treatment of Chronic Kidney Diseases: Theories, Applications, and Mechanisms.
Wang Y, Feng Y, Li M, Yang M, Shi G, Xuan Z
Front Pharmacol. 2022; 13:917975.
PMID: 35924053
PMC: 9340222.
DOI: 10.3389/fphar.2022.917975.
IgA nephropathy treatment with traditional Chinese medicine: A case report.
Zhang Y, Chen Y, Yi L, Gao K
World J Clin Cases. 2022; 10(10):3232-3240.
PMID: 35647137
PMC: 9082689.
DOI: 10.12998/wjcc.v10.i10.3232.
Clinical trial for conventional medicine integrated with traditional Chinese medicine (TCM) in the treatment of patients with chronic kidney disease.
Xi Y, Lu X, Zhu L, Sun X, Jiang Y, He W
Medicine (Baltimore). 2020; 99(21):e20234.
PMID: 32481298
PMC: 7249962.
DOI: 10.1097/MD.0000000000020234.
Combination therapy of chitosan, gynostemma, and motherwort alleviates the progression of experimental rat chronic renal failure by inhibiting STAT1 activation.
Bai W, Wang S, An S, Guo M, Gong G, Liu W
Oncotarget. 2018; 9(21):15498-15511.
PMID: 29643988
PMC: 5884643.
DOI: 10.18632/oncotarget.24125.
Traditional Chinese Medicine for Refractory Nephrotic Syndrome: Strategies and Promising Treatments.
Wang X, Wang L, Tu Y, Zhang Y
Evid Based Complement Alternat Med. 2018; 2018:8746349.
PMID: 29507594
PMC: 5817219.
DOI: 10.1155/2018/8746349.
Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes.
Yuan Z, Jia L, Lim L, Lin J, Shu G, Zhao L
Int J Nanomedicine. 2017; 12:5673-5686.
PMID: 28848346
PMC: 5557620.
DOI: 10.2147/IJN.S141095.
Prescribed Renoprotective Chinese Herbal Medicines Were Associated with a Lower Risk of All-Cause and Disease-Specific Mortality among Patients with Chronic Kidney Disease: A Population-Based Follow-Up Study in Taiwan.
Hsieh C, Chang H, Huang S, Chen C, Chen W, Yang C
Evid Based Complement Alternat Med. 2017; 2017:5632195.
PMID: 28798802
PMC: 5535732.
DOI: 10.1155/2017/5632195.
Renoprotective Effect of the Shen-Yan-Fang-Shuai Formula by Inhibiting TNF-/NF-B Signaling Pathway in Diabetic Rats.
Lv J, Wang Z, Wang Y, Sun W, Zhou J, Wang M
J Diabetes Res. 2017; 2017:4319057.
PMID: 28713834
PMC: 5497613.
DOI: 10.1155/2017/4319057.
Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: A mini review.
Ziaei S, Halaby R
Avicenna J Phytomed. 2016; 6(2):149-64.
PMID: 27222828
PMC: 4877967.
Inhibition of adriamycin-induced nephropathy in rats by herbs based kangshenoral solution.
Zhao J, Lin X, Xiao X, Yang J, Liu H, Yi W
Int J Clin Exp Med. 2016; 8(12):22469-76.
PMID: 26885229
PMC: 4730015.
Hypoxia: The Force that Drives Chronic Kidney Disease.
Fu Q, Colgan S, Shelley C
Clin Med Res. 2016; 14(1):15-39.
PMID: 26847481
PMC: 4851450.
DOI: 10.3121/cmr.2015.1282.
Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease.
Mao W, Zhang L, Zou C, Li C, Wu Y, Su G
BMC Complement Altern Med. 2015; 15:316.
PMID: 26351087
PMC: 4562196.
DOI: 10.1186/s12906-015-0830-1.